key: cord-0788256-lah0fb83 authors: Kashi, A. H.; Fallah-karkan, M.; Amini, E.; Vaezjalali, M. title: The Presence of COVID-19 in Urine: A Systematic Review and Meta-analysis of the Literature date: 2020-05-18 journal: nan DOI: 10.1101/2020.05.15.20094920 sha: dd4dcb38b62bd70f99436636e09c2cba0bac5c07 doc_id: 788256 cord_uid: lah0fb83 Purpose: To investigate the literature on the presence of COVID-19 virus in urine of infected patients and evaluate the attributes and clinical significance of COVID-19 in urine including probability of infection transmission through urine. Data sources: A systematic review of literature from December 2019 to 6th May 2020 was conducted on Pubmed, google scholar, ovid, scopus and ISI web of science. Study eligibility criteria: Studies which investigated urinary viral shedding of COVID-19 in infected patients included. Study appraisal and synthesis methods: Two reviewers selected relative studies and performed quality assessment of individual studies. Meta-analysis was performed the pooled case reports and case series. Fixed-effects model was used for analysis as no significant heterogeneity was observed between studies. Results: Thirty three studies were finally included in the systematic review including 19 case reports, 13 case series, and one cohort. Urinary samples from 430 patients were investigated. Ten studies reported the presence of COVID-19 in urinary samples from 16 patients. The rate of COVID-19 presence in urinary samples was 3.7%. Urinary viral load was low in most reports. The presence of virus in urine was not related to the disease course of the illness. Urinary COVID-19 was mostly detected from patients with moderate to severe disease (13 pts) but was also isolated from two children (one neonate and one 7 year-old girl) with mild disease. The pathogenicity of virus isolated from urine has been demonstrated in cell culture media in one study. Conclusions: This review highlights the low frequency of COVID-19 presence in urine of infected individuals and the potential of isolated virus for cytopathic effects. Therefore the probability of infection transmission through urine can be suggested. Caution must be exerted when dealing with urine of patients infected with COVID-19 including medical interventions like endoscopy and urethral catheterization. Novel coronavirus disease first reported form Wuhan is a new disease caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), manifesting as an acute respiratory illness, however the involvement of multiple organs including kidney has been reported 1 . The pathophysiological mechanisms for SARS-CoV-2 infection and organ invasion are not yet fully discovered, which leads to difficulties in understanding routes of transmission, clinical diagnosis and treatment 2 . Genomic sequence analysis indicated that SARS-CoV-2 has 75%-80% genomic similarity to coronavirus causative agent for severe acute respiratory syndrome (SARS) namely SARS-CoV 3 . In previous reports of SARS and the Middle East respiratory syndrome coronavirus (MERS-CoV) infections, acute kidney injury was observed in 5% to 15% cases and was associated with a high (60%-90%) mortality rate 4 . The angiotensin-converting enzyme 2 (ACE2), known to be a cell receptor for human SARS-CoV, is also reported to play the same role for cellular entry of SARS-CoV-2 5 . In addition to respiratory organs, upregulation of ACE2 expression was also identified in urogenital system including kidney proximal tubule cells, bladder urothelial cells 6 and genital organs including testis 7, 8 . The widely accepted routes of human to human transmission for COVID-19 are through respiratory droplets and direct contact, however viral shedding in urine has been reported and infection transmission through infected urine remains a possibility. The idea of virus transmission thorough urine originated form the homogeneity of viral SARS-CoV-2 genome with SARS virus and the abundant previous evidence on the presence of SARS virus in urine 9, 10 . Original protocols for sample collections from COVID-19 patients included urine sample collection 11 . Nevertheless, All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05. 15.20094920 doi: medRxiv preprint the mechanism of virus shedding urine is unclear. Two suggested mechanisms for SARS-CoV-2 shedding in urine have been proposed: Firstly, Sepsis and cytokine storm results in renal dysfunction and subsequent leakage of SARS-CoV-2 from circulation into urine; Secondly, virus may directly invade the urinary system via binding to ACE2 receptors and shed into the urine 12 . Although the virus shedding into the urine is hypothetically probable, most studies showed that virus is absent in the urine of infected patients 6, [13] [14] [15] . However, contradicting results exist in the literature as virus shedding was found in some studies 1, 16, 17 . Therefore, we performed a systematic review on the published literature to provide a summary of evidence on detection of SARS-CoV-2 in urinary samples. We conducted a comprehensive systematic literature review of online databases, including Web of Science, PubMed, Scopus, Ovid, and google scholar from 1 st December 2019 till 6t h May 2020. The search was performed by two independent investigators. The search terms used was: "(covid-19 OR ncovid-19 OR sars-cov-2 OR covid OR ncovid) AND urine". Database searching was started on March 29 th 2020 and was regularly updated during extraction and analysis of retrieved studies to find newly published articles. The latest electronic search on cited databases was performed on May 6 th , 2020. References of retrieved articles were manually searched to find eligible studies. The search and selection criteria were restricted to English language. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The title and abstract of retrieved studies were screened through two different researchers independently. After removing duplicates and irrelevant studies, the full texts of articles were examined for presence of original data on the presence of COVID-19 in urine ( Figure 1 ). Any disagreement was resolved by a third person. Personal viewpoints, opinion articles, correspondence, and letters not presenting original data were excluded as well as studies which did not report their result of urinary testing for COVID-19. Locations of studies was noted to identify duplicate case reports/series from the same area. When there was reports from the same area or suspicion of reports from same population of patients, authors were contacted to confirm independence in population of patients. All the search results were evaluated in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The results of the search revealed 33 studies suitable for meta-analysis. The main outcome in this study is the evaluation of virus shedding into the urine of patients infected with COVID-19. Data were extracted from the eligible manuscripts into pre-defined datafields including study location, sample size, mean or median age, gender of patients, illness category, total number of patients and/or urine samples tested, urine assessment technique, total number of positive urine samples, and sampling time. The included studies were evaluated in terms of quality according to the quality assessment tool for case series reported by the National Heart, Lung, and Blood Institute form the National All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05. 15.20094920 doi: medRxiv preprint Institutes of Health 18 . This tools evaluates the quality based on a 9 item questionnaire. The questions focus on study population description, case definition, methods of including cases, comparability of included cases, description of interventions or assessments, follow-up and statistical methods used. The total score ranges from 0-9. Scores ≤ 3 were considered poor. Score of 4-6 was considered fair and score of 7-9 was considered good in terms of quality (Table 1) . Extracted data from 33 studies were used for statistical analysis. Case reports and case series with a sample size of 6 or less were cumulated into one case series with sample size of 37 including 12 case reports and 7 case series. Thirteen case series and one cohort study with sample size of 9 or higher were also included in meta-analysis. The effect size of individual studies was calculated by weighting each one of them by its inverse variance, and a confidence interval (CI) was thus obtained 19 . Each study was weighted inversely proportional to its variance. To calculate the variance of each study, a binomial distribution was used. To investigate heterogeneity, the Q statistics and I2 index with α significance level of less than 10% were used. In this study, the random-effects model was considered, when there is heterogeneity among the studies (I2> 50%). The authors used the Egger's test to check publication bias. In this study, Metaprop command in STATA used to stabilize the variances 20 . STATA software (version 16) was used to analyze the data. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05. 15.20094920 doi: medRxiv preprint The relationship between disease severity in each study and frequency of viral shedding in urine was investigated by weighting each study according to its sample size and performing spearman correlation. A total of 1112 articles were retrieved using the search strategy mainly through google scholar search engine. After studying the title and abstract of studies, and removing duplicate studies, the number was reduced to 146 studies. Full text of these 146 studies were studied and non-original studies including communications without original data, personal reviews and letters were excluded resulting in 33 articles. (Figure 1 ) These 33 articles include one formally unpublished article retrieved by google scholar search engine from a database of unpublished studies (medRxiv). There were 12 case reports, 20 case series, and one cohort study from 12 different countries. The characteristics of the included studies are shown in Table 1 . Out of the total reported population of 1870 patients in these 33 studies, urinary testing has been performed on 430 patients during admission and up to day 52 after illness onset. Positivity of urinary specimens were reported in 10 studies ranging from 1 to 4 positive urinary samples in each study summing to a total of 16 patients through 12, day 30, and day 52 after illness onset. The patient urine sample that was considered All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05.15.20094920 doi: medRxiv preprint positive in day 52 in this review was not positive on urine but was positive on urinary sediment. Excluding studies with a sample size of 1-2 patients, the percent positivity of COVID-19 in urine samples of different included studies varies from zero in most reports to as high as 11 percent in a 2 reports of 9 patients from Guangdong, and Guangzhou 2,21 on adults and children. The meta-analysis forest plot which takes into account the weight of each study according to the inverse of its variance revealed a pooled estimate of 1.23% (CI 95%: 0.12 -3.06%) for viral shedding in urine of patients ( Figure 2 ). Meta-regression analysis revealed that the positivity rate after symptom onset. The patient urine sample turned negative on day 10 after symptom onset. In this study, virus quantity in urine sample was lower than rectal and oropharyngeal samples. The patient with positive urinary PCR for COVID-19 did not complain of any urinary symptoms 2 . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. In another study on children, the urine sample of 1 out of nine infected children was positive for COVID-19 by real time RT-PCR. All children in this study suffered from asymptomatic or mild disease. The urine was positive in a 7 year-old girl who presented only with fever (38.7 ° C) without cough or respiratory symptoms 21 . In a landmark study, Sun and colleagues investigated the urine samples of a 72 year-old male with severe COVID-19 infection. Urinary sampling was performed on days 12, 30 and 42 after symptom onset. The viral load was above diagnostic threshold only on day 30. The authors inoculated Vero E6 cells with urine of patient on day 12 (with viral load below diagnostic All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. assumption, heart, lung, esophagus, ileum, bladder, and kidneys has been suggested as potential All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05.15.20094920 doi: medRxiv preprint organs for COVID-19 invasion 26 . Also in another study, the expression of ACE2 in testis has been demonstrated 7 . Therefore, the possibility of viral shedding in urine and semen can be postulated 7 . Urinary samples were not routinely collected in earliest infected patients in the initial outbreak of COVID-19 in many countries due to delay in proper diagnosis of COVID-19 in patients referring with respiratory symptoms 30 . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05. 15.20094920 doi: medRxiv preprint In most reports that have reported the presence of virus in urinary samples, the quantity of virus in urinary samples have been low in comparison with rectal or pharyngeal specimens 2 or has been marginally above the diagnostic threshold of the PCR assay 22 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05. 15.20094920 doi: medRxiv preprint He authors report on conflict of interest. No funding was available for the current meta-analysis. AHK concepted of the study, helped in data gathering, helped in data analysis, and drafted the article. MF helped in data gathering and in revising the manuscript. EA helped in data gathering and in manuscript revision. MV helped in data gathering, drafting the manuscript, and revising manuscript. All authors approved the final version of the manuscript. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. Studies included in quantitative synthesis (meta-analysis) (n = 33 ) All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05.15.20094920 doi: medRxiv preprint Figure 2 . Forest plot of the frequency of urinary viral shedding in each study and the pooled estimate. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05.15.20094920 doi: medRxiv preprint Clinical Characteristics of Coronavirus Disease 2019 in China Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding COVID-19, SARS and MERS: are they closely related? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection Absence of 2019 Novel Coronavirus in Semen and Testes of COVID-19 Patients COVID-19 and Semen: An Unanswered Area of Research COVID-19, Urologists and Hospitals Epidemiology, Pathogenesis, and Control of COVID-19 Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. World Health Organization The novel coronavirus 2019 epidemic and kidneys Virological assessment of hospitalized patients with COVID-2019 Detection of SARS-CoV-2 in Different Types of Clinical Specimens Viral load of SARS-CoV-2 in clinical samples. The Lancet Infectious Diseases Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Confidence intervals for the overall effect size in randomeffects meta-analysis Metaprop: a Stata command to perform meta-analysis of binomial data. Archives of public health = Archives belges de sante Clinical characteristics and radiological features of children infected with the 2019 novel coronavirus Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Isolation of Infectious SARS-CoV-2 from Urine of a COVID-19 Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection COVID-19 and Urology: A Comprehensive Review of the Literature. 2020. 27. Organization WH. Coronavirus disease 2019 (COVID-19) Situation Report -107. World Health Organization The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019 Structure of SARS coronavirus spike receptor-binding domain complexed with receptor Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China Severity Detection For the Coronavirus Disease Patients Using a Machine Learning Model Based on the Blood and Urine Tests Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 First Pediatric Case of Coronavirus Disease Duration of viral detection in throat and rectum of a patient with COVID-19 The index case of SARS-CoV-2 in Scotland: a case report Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first diagnosis of COVID-19 in Australia A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes A well infant with coronavirus disease 2019 (COVID-19) with high viral load A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients Journal of endocrinological investigation 2020. 50. Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States Clinical and virological data of the first cases of COVID-19 in Europe: a case series Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau